Scott W. Morrison - 30 Sep 2024 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Scott Sieckert, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
30 Sep 2024
Net transactions value
$0
Form type
4
Filing time
02 Oct 2024, 17:27:04 UTC
Previous filing
17 Sep 2024
Next filing
13 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Gift $0 -6,016 -100% $0.000000 0 30 Sep 2024 Direct F1
holding TARS Common Stock 6,016 30 Sep 2024 By Morrison-Minton Family 2004 Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person transferred 6,016 shares of common stock to the Morrison-Minton Family 2004 Trust for no consideration. The Reporting Person is trustee of the Morrison-Minton Family 2004 Trust, and the Reporting Person and his spouse are the sole beneficiaries of the trust.